Gene · 5336
Papers3,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia. | Leukemia | 2024 | 38914716 | PubTator, text mining | PubMed |
| Richter transformation acquiring PLCG2 mutation during Bruton tyrosine kinase inhibitors treatment. | EJHaem | 2024 | 38895067 | PubTator, text mining | PubMed |
| METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth. | Cancer Lett | 2024 | 38880226 | PubTator, text mining | PubMed |
| A Review of Resistance Mechanisms to Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2024 | 38791284 | PubTator, text mining | PubMed |
| The LAT Rheostat as a Regulator of Megakaryocyte Activation. | Thromb Haemost | 2024 | 38788774 | PubTator, text mining | PubMed |
| PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer. | Mol Cancer | 2024 | 38778348 | PubTator, text mining | PubMed |
| Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib. | Blood | 2024 | 38754046 | PubTator, text mining | PubMed |
| Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. | Leukemia | 2024 | 38750139 | PubTator, text mining | PubMed |
| Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma. | Hematol Oncol | 2024 | 38676394 | PubTator, text mining | PubMed |
| WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor. | Thromb Res | 2024 | 38669962 | PubTator, text mining | PubMed |
| Sphingosine-1-Phosphate Shapes Healthy Monocytes into An Immunosuppressive Phenotype. | Cell Physiol Biochem | 2024 | 38639213 | PubTator, text mining | PubMed |
| Cognitively healthy centenarians are genetically protected against Alzheimer's disease. | Alzheimers Dement | 2024 | 38634500 | PubTator, text mining | PubMed |
| POU2F3-positive small cell carcinoma of the bladder: A clinicopathologic analysis of 4 cases and literature review. | Pathol Res Pract | 2024 | 38615507 | PubTator, text mining | PubMed |
| Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. | Blood Adv | 2024 | 38598725 | PubTator, text mining | PubMed |
| A novel micellular fluorogenic substrate for quantitating the activity of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma (PLCγ) enzymes. | PLoS One | 2024 | 38551930 | PubTator, text mining | PubMed |
| Synthetic Circular RNA for microRNA-1269a Suppresses Tumor Progression in Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2024 | 38539573 | PubTator, text mining | PubMed |
| Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain-of-function variations. | Eur J Haematol | 2024 | 38529725 | PubTator, text mining | PubMed |
| In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. | Blood Adv | 2024 | 38507738 | PubTator, text mining | PubMed |
| B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression. | Sci Rep | 2024 | 38503806 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis of vestibular schwannoma reveals functionally distinct macrophage subsets. | Br J Cancer | 2024 | 38480935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5336/papers?page=11